Literature DB >> 14760957

Peer support groups in multiple sclerosis: current effectiveness and future directions.

M Messmer Uccelli1, L Mancuso Mohr, M A Battaglia, P Zagami, D C Mohr.   

Abstract

Peer support programs have become a common method of providing support for patients with chronic illness. Utilizing peers as resources has been proposed as an effective means for coping with a stressful life experience and for gaining support from others who share a common factor, although data are somewhat mixed on the efficacy of peer support. The aim of the present study was to evaluate the effectiveness of eight weeks of a standard form of peer support in improving quality of life and reducing depressive symptoms in 44 patients with multiple sclerosis (MS). One person from each of six groups participated in a training course in order to learn basic principles of peer support. Eight weekly sessions were held and patients completed self-administered questionnaires pre- and post-treatment assessing quality of life and depression. Results showed that support groups do not provide consistent improvement in quality of life or depression in patients with MS and suggest that patients who have better mental health functioning could be at risk for deterioration in support groups.

Entities:  

Mesh:

Year:  2004        PMID: 14760957     DOI: 10.1191/1352458504ms973oa

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  16 in total

1.  What are the support needs of men with multiple sclerosis, and are they being met?

Authors:  Dominic Upton; Charlotte Taylor
Journal:  Int J MS Care       Date:  2015 Jan-Feb

2.  [Coping training for patients with multiple sclerosis. Evaluation from a neurologic standpoint].

Authors:  S Twork; K H Schwermer; J Kugler
Journal:  Nervenarzt       Date:  2007-04       Impact factor: 1.214

Review 3.  Depression in multiple sclerosis: a review.

Authors:  R J Siegert; D A Abernethy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-04       Impact factor: 10.154

Review 4.  Update on depression in neurologic illness: stroke, epilepsy, and multiple sclerosis.

Authors:  Richard M Sobel; Susan Lotkowski; Steven Mandel
Journal:  Curr Psychiatry Rep       Date:  2005-10       Impact factor: 5.285

Review 5.  Mental Health Comorbidity in MS: Depression, Anxiety, and Bipolar Disorder.

Authors:  Aaron P Turner; Kevin N Alschuler; Abbey J Hughes; Meghan Beier; Jodie K Haselkorn; Alicia P Sloan; Dawn M Ehde
Journal:  Curr Neurol Neurosci Rep       Date:  2016-12       Impact factor: 5.081

6.  Association of social network structure and physical function in patients with multiple sclerosis.

Authors:  Seth N Levin; Claire S Riley; Amar Dhand; Charles C White; Shruthi Venkatesh; Blake Boehm; Caren Nassif; Lauren Socia; Kaho Onomichi; Victoria M Leavitt; Libby Levine; Rock Heyman; Rebecca S Farber; Wendy S Vargas; Zongqi Xia; Philip L De Jager
Journal:  Neurology       Date:  2020-08-07       Impact factor: 9.910

Review 7.  Depression and immunity: inflammation and depressive symptoms in multiple sclerosis.

Authors:  Stefan M Gold; Michael R Irwin
Journal:  Immunol Allergy Clin North Am       Date:  2009-05       Impact factor: 3.479

Review 8.  Psychosocial interventions in people with multiple sclerosis: a review.

Authors:  K S Malcomson; L Dunwoody; A S Lowe-Strong
Journal:  J Neurol       Date:  2007-02-14       Impact factor: 4.849

9.  Support Group Participation: Effect on Perceptions of Patients with Newly Diagnosed Multiple Sclerosis.

Authors:  Meghan Garabedian; Erin Perrone; Caitlin Pileggi; Vanessa Zimmerman
Journal:  Int J MS Care       Date:  2019-10-08

10.  Selective serotonin reuptake inhibitor attenuates the hyperresponsiveness of TLR2+ and TLR4+ Th17/Tc17-like cells in multiple sclerosis patients with major depression.

Authors:  Marisa C Sales; Taissa M Kasahara; Priscila M Sacramento; Átila D Rossi; Marcos Octávio S D Cafasso; Hugo A A Oyamada; Joana Hygino; Fabianna Alvim; Regis M Andrade; Cláudia Cristina Vasconcelos; Cleonice A M Bento
Journal:  Immunology       Date:  2020-11-23       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.